Clinical management of thalassemia. The status of new iron chelators

Ann N Y Acad Sci. 1980:344:425-35. doi: 10.1111/j.1749-6632.1980.tb33682.x.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Chelating Agents* / metabolism
  • Chelating Agents* / pharmacology
  • Chemical Phenomena
  • Chemistry
  • Cholic Acids / pharmacology
  • Deferoxamine / pharmacology
  • Drug Evaluation
  • Drug Evaluation, Preclinical
  • Enterobactin / analogs & derivatives
  • Enterobactin / pharmacology
  • Ethylenediamines / pharmacology
  • Humans
  • Hydroxamic Acids / pharmacology
  • Hydroxybenzoates / pharmacology
  • Iron / metabolism
  • Pentetic Acid / pharmacology
  • Piperazines / pharmacology
  • Thalassemia / drug therapy

Substances

  • Chelating Agents
  • Cholic Acids
  • Ethylenediamines
  • Hydroxamic Acids
  • Hydroxybenzoates
  • Piperazines
  • ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)
  • cholylhydroxamic acid
  • Enterobactin
  • rhodotorulic acid
  • 2,3-dihydroxybenzoic acid
  • Pentetic Acid
  • Iron
  • Deferoxamine